Remifentanil repairs cartilage damage and reduces the degradation of cartilage matrix in post-traumatic osteoarthritis, and inhibits IL-1β-induced apoptosis of articular chondrocytes via inhibition of PI3K/AKT/NF-κB phosphorylation

Hai Ke; Xiaping Mou; Qing Xia

Journal ArticleOPEN ACCESS

Remifentanil repairs cartilage damage and reduces the degradation of cartilage matrix in post-traumatic osteoarthritis, and inhibits IL-1β-induced apoptosis of articular chondrocytes via inhibition of PI3K/AKT/NF-κB phosphorylation

Ke H
Mou X
Xia Q

Annals of Translational Medicine (2020) 8(22) 1487-1487

DOI: 10.21037/atm-20-6000

N/ACitations

6Readers

Abstract

Background: Remifentanil (RFT) is an opioid analgesic with a unique pharmacokinetic profile, and plays

Cite

CITATION STYLE

APA

Ke, H., Mou, X., & Xia, Q. (2020). Remifentanil repairs cartilage damage and reduces the degradation of cartilage matrix in post-traumatic osteoarthritis, and inhibits IL-1β-induced apoptosis of articular chondrocytes via inhibition of PI3K/AKT/NF-κB phosphorylation. Annals of Translational Medicine, 8(22), 1487–1487. https://doi.org/10.21037/atm-20-6000

Remifentanil repairs cartilage damage and reduces the degradation of cartilage matrix in post-traumatic osteoarthritis, and inhibits IL-1β-induced apoptosis of articular chondrocytes via inhibition of PI3K/AKT/NF-κB phosphorylation

Abstract

Cite

Register to see more suggestions